Literature DB >> 11083192

Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality.

G S Thomas1, N V Prill, H Majmundar, R R Fabrizi, J J Thomas, C Hayashida, S Kothapalli, J L Payne, M M Payne, M I Miyamoto.   

Abstract

BACKGROUND: Combining low-level treadmill exercise with adenosine infusion may result in fewer bradyarrhythmic complications by increasing sympathetic tone and may improve myocardial perfusion image quality by decreasing background activity.
METHODS: Patients referred for outpatient pharmacologic stress myocardial perfusion imaging performed simultaneous treadmill exercise (mean 2.2 metabolic equivalents) throughout 6-minute adenosine infusion (adenosine-exercise n = 507). Patients unable to exercise and those with left bundle branch block received adenosine infusion alone (adenosine-nonexercise n = 286). Adverse reaction data were collected on all patients and compared by sex. Background-to-target activity was calculated in a blinded fashion on 200 randomly selected patients.
RESULTS: During the period from April 1996 to December 1998, 507 patients (64%) underwent adenosine-exercise testing, whereas 286 (36%) underwent adenosine-nonexercise testing. Hypotensive and arrhythmic (atrioventricular block, sinus bradycardia, and new onset atrial fibrillation or flutter) adverse reactions occurred less often during adenosine-exercise than during adenosine-nonexercise. Neither death nor myocardial infarction occurred in either group. In the adenosine-exercise group, 2.8% of patients experienced an adverse reaction versus 5.6% of the adenosine-nonexercise group (P = .04). The reduction in adverse reactions occurred in both men and women, although women had significantly more adverse reactions than men (5.7% vs 1.8%, P = .004). Liver/heart and gut/heart ratios were lower in the adenosine-exercise group (1.05+/-0.42 vs. 1.21+/-0.55 , P = .01; 0.61+/-0.21 vs. 0.69+/-0.24, P = .03, respectively).
CONCLUSIONS: Compared with adenosine infusion alone, combining low-level treadmill exercise with adenosine in outpatients is safe, better tolerated, and improves image quality. Women were more likely to experience adverse reactions than men.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083192     DOI: 10.1067/mnc.2000.108030

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  15 in total

1.  Simultaneous low level treadmill exercise and intravenous dipyridamole stress thallium imaging.

Authors:  P N Casale; T E Guiney; H W Strauss; C A Boucher
Journal:  Am J Cardiol       Date:  1988-10-01       Impact factor: 2.778

2.  Exercise-dipyridamole myocardial perfusion imaging: the circle is now complete.

Authors:  K A Brown
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

3.  Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men.

Authors:  B A Kong; L Shaw; D D Miller; B R Chaitman
Journal:  Am J Cardiol       Date:  1992-07-15       Impact factor: 2.778

4.  Complications of exercise and pharmacologic stress tests: differences in younger and elderly patients.

Authors:  A Hashimoto; E L Palmar; J A Scott; S A Abraham; A J Fischman; T L Force; J B Newell; C A Rabito; G D Zervos; T Yasuda
Journal:  J Nucl Cardiol       Date:  1999 Nov-Dec       Impact factor: 5.952

5.  Frequency of extra-cardiac activity and its effect on 99Tcm-MIBI cardiac SPET interpretation.

Authors:  P K Rehm; F B Atkins; H A Ziessman; S E Green; E A Akin; L M Fox; D J Hixson
Journal:  Nucl Med Commun       Date:  1996-10       Impact factor: 1.690

6.  Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry.

Authors:  M D Cerqueira; M S Verani; M Schwaiger; J Heo; A S Iskandrian
Journal:  J Am Coll Cardiol       Date:  1994-02       Impact factor: 24.094

7.  Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: a comparison in 2,000 patients.

Authors:  D L Johnston; J R Daley; D O Hodge; M R Hopfenspirger; R J Gibbons
Journal:  Mayo Clin Proc       Date:  1995-04       Impact factor: 7.616

8.  Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease.

Authors:  A P Ignaszewski; L X McCormick; P G Heslip; A J McEwan; D P Humen
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

9.  The VEX-test for myocardial scintigraphy with thallium-201 and sestamibi: effect on abdominal background activity.

Authors:  G A Hurwitz; S Saddy; J P O'Donoghue; S A Ali; J E Powe; M Husni; D R Gravelle
Journal:  J Nucl Med       Date:  1995-06       Impact factor: 10.057

10.  Dipyridamole thallium testing: noncardiac side effects, cardiac effects, electrocardiographic changes and hemodynamic changes after dipyridamole infusion with and without exercise.

Authors:  G J Laarman; M G Niemeyer; E E van der Wall; F J Verzijlbergen; T L Go; A V Bruschke; C A Ascoop
Journal:  Int J Cardiol       Date:  1988-08       Impact factor: 4.164

View more
  40 in total

Review 1.  Pharmacologic stress testing: new methods and new agents.

Authors:  Robert C Hendel; Tariq Jamil; David K Glover
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

Review 2.  An overview of contemporary nuclear cardiology.

Authors:  Howard C Lewin; Maria G Sciammarella; Thomas A Watters; Herbert G Alexander
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

3.  A helping hand for regadenoson tests.

Authors:  Preeti Kansal; Thomas A Holly
Journal:  J Nucl Cardiol       Date:  2015-10-22       Impact factor: 5.952

4.  EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology.

Authors:  B Hesse; K Tägil; A Cuocolo; C Anagnostopoulos; M Bardiés; J Bax; F Bengel; E Busemann Sokole; G Davies; M Dondi; L Edenbrandt; P Franken; A Kjaer; J Knuuti; M Lassmann; M Ljungberg; C Marcassa; P Y Marie; F McKiddie; M O'Connor; E Prvulovich; R Underwood; B van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

5.  Stress protocols and tracers.

Authors:  Milena J Henzlova; Manuel D Cerqueira; John J Mahmarian; Siu-Sun Yao
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 6.  Pharmacologic stress myocardial perfusion imaging: a practical approach.

Authors:  Michael I Miyamoto; Sharon L Vernotico; Haresh Majmundar; Gregory S Thomas
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

7.  Best patient preparation before and during radionuclide myocardial perfusion imaging studies.

Authors:  Lisa A Boger; Lyndy L Volker; Ginger K Hertenstein; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

8.  Should PET replace SPECT for evaluating CAD? The end of the beginning.

Authors:  Marcelo F Di Carli; Rory Hachamovitch
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

9.  Symptom-limited exercise combined with dipyridamole stress: prognostic value in assessment of known or suspected coronary artery disease by use of gated SPECT imaging.

Authors:  Alan W Ahlberg; Sarkis B Baghdasarian; Haris Athar; Jeffrey P Thompsen; Deborah M Katten; Gavin L Noble; Igor Mamkin; Anuj R Shah; Ivette A Leka; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

10.  Symptom-limited exercise during vasodilator stress: best of both worlds?

Authors:  Kevin A Bybee; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.